The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.554 · Cited by 5,299
Dissociation Constants of Organic Bases in Aqueous Solution
PERRIN, D. D. (1965) · Medical Entomology and Zoology · Cited by 1,795
Zhang, W., Doherty, M., Leeb, B. F., Alekseeva, L., Arden, N. K., Bijlsma, J. W., Dinçer, F., Dziedzic, K., Häuselmann, H. J., Herrero-Beaumont, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062091 · Cited by 1,338
Zacks, C. M., Abbott, R. L., & Fine, M. (1990) · Cornea · doi:10.1097/00003226-199004000-00002 · Cited by 1,234
McGettigan, P., & Henry, D. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,096
Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., & Khamashta, M. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101766 · Cited by 978
Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling
Wiegmann, K., Schütze, S., Machleidt, T., Witte, D., & Krönke, M. (1994) · Cell · doi:10.1016/0092-8674(94)90275-5 · Cited by 714
Hydroxychloroquine: From Malaria to Autoimmunity
Ben-Zvi, I., Kivity, S., Langevitz, P., & Shoenfeld, Y. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8243-x · Cited by 613
Van Der Heijde, D., Van Riel, P., Gribnau, F., Nuver-Zwart, I., & Van De Putte, L. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92442-2 · Cited by 556
Lysosomes, pH and the Anti-malarial Action of Chloroquine
HOMEWOOD, C. A., WARHURST, D. C., PETERS, W., & BAGGALEY, V. C. (1972) · Nature · doi:10.1038/235050a0 · Cited by 530
Pettipher, E. R., Higgs, G. A., & Henderson, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.22.8749 · Cited by 496
Brucato, A., Frassi, M., Franceschini, F., Cimaz, R., Faden, D., Pisoni, M. P., Muscar�, M., Vignati, G., Stramba-Badiale, M., Catelli, L., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200108)44:8<1832::aid-art320>3.0.co;2-c · Cited by 494
Mechanism of action of hydroxychloroquine as an antirheumatic drug
Fox, R. I. (1993) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(10)80012-5 · Cited by 430
Sneader, W. (2005) · Wiley eBooks · doi:10.1002/0470015535 · Cited by 427
Brentano, F., Schorr, O., Gay, R. E., Gay, S., & Kyburz, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21273 · Cited by 377
Recommendations on screening for chloroquine and hydroxychloroquine retinopathy
Marmor, M. F., Carr, R. E., Easterbrook, M., Farjo, A. A., & Mieler, W. F. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01168-5 · Cited by 371
RETINOPATHY FOLLOWING CHLOROQUINE THERAPY
Hobbs, H. E., Sorsby, A., & Freedman, A. (1959) · The Lancet · doi:10.1016/s0140-6736(59)90604-x · Cited by 343
ELECTRON MICROSCOPY OF LYSOSOME-RICH FRACTIONS FROM RAT LIVER
Novikoff, A. B., Beaufay, H., & de Duve, C. (1956) · The Journal of Cell Biology · doi:10.1083/jcb.2.4.179 · Cited by 330
GALLSTONE DISAPPEARANCE ASSOCIATED WITH WEIGHT LOSS
Thornton, J. R. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91537-x · Cited by 329
TREATMENT OF LUPUS ERYTHEMATOSUS WITH MEPACRINE
Page, F. (1951) · The Lancet · doi:10.1016/s0140-6736(51)91643-1 · Cited by 317
Costedoat‐Chalumeau, N., Amoura, Z., Duhaut, P., Huong, D. L. T., Sebbough, D., Wechsler, B., Vauthier, D., Denjoy, I., Lupoglazoff, J., & Piette, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11304 · Cited by 314
Gottenberg, J.-E., Ravaud, P., Puéchal, X., Le Guern, V., Sibilia, J., Goeb, V., Larroche, C., Dubost, J.-J., Rist, S., Saraux, A., et al. (2014) · JAMA · doi:10.1001/jama.2014.7682 · Cited by 311
Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate
McChesney, E. W. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91265-2 · Cited by 310
Pons‐Estel, G. J., Alarcón, G. S., McGwin, G., Danila, M. I., Zhang, J., Bastian, H. M., Reveille, J. D., & Vilá, L. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24538 · Cited by 306
Jang, C.-H., Choi, J.-H., Byun, M.-S., & Jue, D.-M. (2006) · Rheumatology · doi:10.1093/rheumatology/kei282 · Cited by 305
Sneader, W. (2005) · Cited by 302
Jung, H., Bobba, R., Su, J., Shariati‐Sarabi, Z., Gladman, D. D., Urowitz, M., Lou, W., & Fortin, P. R. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27289 · Cited by 291
Seror, R., Theander, E., Brun, J. G., Ramos-Casals, M., Valim, V., Dörner, T., Bootsma, H., Tzioufas, A., Solans-Laqué, R., Mandl, T., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204615 · Cited by 290
Clinical Pharmacokinetics and Metabolism of Chloroquine: Focus on Recent Advancements
Ducharme, J., & Farinotti, R. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631040-00003 · Cited by 289
Predictors of organ damage in systemic lupus erythematosus: The Hopkins Lupus Cohort
Petri, M., Purvey, S., Fang, H., & Magder, L. S. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34672 · Cited by 277
Bioavailability of hydroxychloroquine tablets in healthy volunteers.
Tett, S., Cutler, D., Day, R., & Brown, K. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03439.x · Cited by 269
Clinical Pharmacokinetics of Antimalarial Drugs
White, N. J. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510030-00001 · Cited by 267
Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis
Petri, M. (1996) · Lupus · doi:10.1177/0961203396005001051 · Cited by 260
Hydroxychloroquine Reverses Thrombogenic Properties of Antiphospholipid Antibodies in Mice
Edwards, M. H., Pierangeli, S., Liu, X., Barker, J. H., Anderson, G., & Harris, E. N. (1997) · Circulation · doi:10.1161/01.cir.96.12.4380 · Cited by 250
Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritis
Munster, T., Gibbs, J. P., Shen, D., Baethge, B. A., Botstein, G. R., Caldwell, J., Dietz, F., Ettlinger, R., Golden, H. E., Lindsley, H., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10307 · Cited by 249
Izmirly, P. M., Kim, M. Y., Llanos, C., Le, P. U., Guerra, M. M., Askanase, A. D., Salmon, J. E., & Buyon, J. P. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119263 · Cited by 248
Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials
Mackenzie, A. H. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91269-x · Cited by 242
Effects of fat-soluble compounds on lysosomes in vitro
Duve, C. D., Wattiaux, R., & Wibo, M. (1962) · Biochemical Pharmacology · doi:10.1016/0006-2952(62)90015-1 · Cited by 238
THE CHEMOSUPPRESSION OF CHEMOTAXIS
Ward, P. A. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.2.209 · Cited by 234
Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases
Furst, D. E. (1996) · Lupus · doi:10.1177/0961203396005001041 · Cited by 233
Li, X.-Q., Bj�rkman, A., Andersson, T. B., Gustafsson, L. L., & Masimirembwa, C. M. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0636-9 · Cited by 232
Kruize, A. A., Hené, R. J., Kallenberg, C. G., van Bijsterveld, O. P., van der Heide, A., Kater, L., & Bijlsma, J. W. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.5.360 · Cited by 226
The separation and characterization of subcellular particles.
Duve, C. D. (1965) · PubMed · Cited by 223
Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study
Fox, R., Dixon, R., Guarrasi, V, & Krubel, S. (1996) · Lupus · doi:10.1177/0961203396005001081 · Cited by 217
Rand, J. H., Wu, X.-X., Quinn, A. S., Chen, P. P., Hathcock, J. J., & Taatjes, D. J. (2008) · Blood · doi:10.1182/blood-2008-03-144204 · Cited by 215
Clinical Pharmacokinetics of Low-Dose Pulse Methotrexate in Rheumatoid Arthritis
Bannwarth, B., Péhourcq, F., Schaeverbeke, T., & Dehais, J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630030-00002 · Cited by 206
Antimalarials in the management of discoid and systemic lupus erythematosus
L. Dubois, E. (1978) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(78)90033-1 · Cited by 189
Sisó, A., Ramos-Casals, M., Bové, A., Brito-Zerón, P., Soria, N., Muñoz, S., Testi, A., Plaza, J., Sentís, J., & Coca, A. (2008) · Lupus · doi:10.1177/0961203307086503 · Cited by 189
Projean, D., Baune, B., Farinotti, R., Flinois, J.-P., Beaune, P., Taburet, A.-M., & Ducharme, J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.748 · Cited by 185
The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe
Cervera, R., Khamashta, M., & Hughes, G. (2009) · Lupus · doi:10.1177/0961203309106831 · Cited by 181
Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity.
Finbloom, D. S., Silver, K., Newsome, D. A., & Gunkel, R. D. (1985) · PubMed · Cited by 180
Goldman, F. D., Gilman, A. L., Hollenback, C., Kato, R. M., Premack, B. A., & Rawlings, D. J. (2000) · Blood · doi:10.1182/blood.v95.11.3460 · Cited by 178
Katchamart, W., Trudeau, J., Phumethum, V, & Bombardier, C. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.099861 · Cited by 177
Gerstein, H. C., Thorpe, K. E., Wayne Taylor, D., & Brian Haynes, R. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00325-4 · Cited by 169
Yanagishita, M., & Hascall, V. C. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90960-9 · Cited by 168
Matsuzawa, Y., & Hostetler, K. Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70769-8 · Cited by 167
Antimalarial drugs in the treatment of rheumatological diseases.
Rynes, R. I. (1997) · Rheumatology · doi:10.1093/rheumatology/36.7.799 · Cited by 167
Wolfe, F., & Michaud, K. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23811 · Cited by 166
Lim, H.-S., Im, J.-S., Cho, J.-Y., Bae, K.-S., Klein, T. A., Yeom, J.-S., Kim, T.-S., Choi, J.-S., Jang, I.-J., & Park, J.-W. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00339-08 · Cited by 163
Biochemical characterization of ADP-ribose polymer metabolism in SLE
Chen, H.-Y., Pertusi, R., Kirkland, J., Rubin, B., & Jacobson, E. (1996) · Lupus · doi:10.1177/096120339600500105 · Cited by 162
Kaplan, M. J., Lewis, E. E., Shelden, E. A., Somers, E., Pavlic, R., McCune, W. J., & Richardson, B. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.6020 · Cited by 160
Immunosuppressive potential of antimalarials
Salmeron, G., & Lipsky, P. E. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91266-4 · Cited by 156
Antimalarial agents: Closing the gate on toll‐like receptors?
Lafyatis, R., York, M. R., & Marshak‐Rothstein, A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22157 · Cited by 153
Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes
Kim, K., Park, J. Y., Lee, J., & Lim, S. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02976712 · Cited by 152
Cartilage destruction by matrix degradation products
Yasuda, T. (2006) · Modern Rheumatology · doi:10.1007/s10165-006-0490-6 · Cited by 151
Biochemical properties of anti-inflammatory drugs—III.
Whitehouse, M. W. (1964) · Biochemical Pharmacology · doi:10.1016/0006-2952(64)90148-0 · Cited by 151
Pharmacologic actions of 4-aminoquinoline compounds
Mackenzie, A. H. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91264-0 · Cited by 149
A new model of osteoarthritis in rabbits
Colombo, C., Butler, M., O'BYRNE, E. M., et al. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780260709 · Cited by 149
Thorens, B., & Vassalli, P. (1986) · Nature · doi:10.1038/321618a0 · Cited by 147
Hydroxychloroquine and Glycemia in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus
Penn, S. K., Kao, A. H., Schott, L. L., Elliott, J. R., Toledo, F. G. S., Kuller, L. H., Manzi, S., & Wasko, M. C. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090994 · Cited by 145
Kyburz, D., Brentano, F., & Gay, S. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0292 · Cited by 136
TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders
Karlsson, L., Sun, S., Rao, N. L., Venable, J. D., & Thurmond, R. L. (2007) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152807783334300 · Cited by 133
Ocular Toxicity of Hydroxychloroquine
Tehrani, R., Ostrowski, R. A., Hariman, R., & Jay, W. M. (2008) · Seminars in Ophthalmology · doi:10.1080/08820530802049962 · Cited by 129
Doorenspleet, M. E., Klarenbeek, P. L., de Hair, M. J. H., van Schaik, B. D. C., Esveldt, R. E., van Kampen, A. H. C., Gerlag, D. M., Musters, A. H., Baas, F., Tak, P. P., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202861 · Cited by 129
Chloroquine inhibits proinflammatory cytokine release into human whole blood
Karres, I., Kremer, J.-P., Dietl, I., Steckholzer, U., Jochum, M., & Ertel, W. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.4.r1058 · Cited by 124
Nitric oxide mediates tumor necrosis factor-α cytotoxicity in endothelial cells
Estrada, C., Gómez, C. E., Martin, C., Moncada, S., & González, C. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80832-0 · Cited by 121
Long term effectiveness of antimalarial drugs in rheumatic diseases
Aviña-Zubieta, J. A., Galindo-Rodríguez, G., Newman, S. C., Suarez-Almazor, M. E., & RUSSELL, A. S. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.10.582 · Cited by 120
Girart, M. V., Fuertes, M. B., Domaica, C. I., Rossi, L. E., & Zwirner, N. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3472 · Cited by 118
Merrill, J. T., & Lahita, R. G. (1996) · Lupus · doi:10.1177/096120339600500103 · Cited by 118
Laaksonen, A.-L., Koskiahde, V., & Juva, K. (1974) · Scandinavian Journal of Rheumatology · doi:10.3109/03009747409115809 · Cited by 117
Evidence of transplacental passage of hydroxychloroquine in humans
Costedoat-Chalumeau, N., Amoura, Z., Aymard, G., Huong, D. U. L. T., Wechsler, B., Vauthier-Brouzes, D., Dermer, M. E., Darbois, Y., & Pietté, J. C. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10150 · Cited by 116
Population Pharmacokinetics of Hydroxychloroquine in Patients With Rheumatoid Arthritis
Carmichael, S., Charles, B. G., & Tett, S. E. (2003) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200312000-00005 · Cited by 114
Katz, S. J., & RUSSELL, A. S. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834456bf · Cited by 111
Stereoselectivity in the Pharmacodynamics and Pharmacokinetics of the Chiral Antimalarial Drugs
Brocks, D. R., & Mehvar, R. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00004 · Cited by 110
Influence of hydroxychloroquine on the bioavailability of oral metoprolol
Somer, M., Kallio, J., Pesonen, U., Pyykkö, K. A., Huupponen, R., & Scheinin, M. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00197.x · Cited by 109
INTRAPOPULATION KINETICS OF THE MITOTIC CYCLE
Sisken, J. E., & Morasca, L. (1965) · The Journal of Cell Biology · doi:10.1083/jcb.25.2.179 · Cited by 109
Verstappen, S. M. M., Jacobs, J. W. G., Bijlsma, J. W. J., Heurkens, A. H. M., van Booma-Frankfort, C., ter Borg, E. J., Hofman, D. M., & van der Veen, M. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11170 · Cited by 109
Chiang, G. H., Sassaroli, M., Louie, M. J., Chen, H., Stecher, V. J., & Sperber, K. E. (1996) · Clinical Therapeutics · doi:10.1016/s0149-2918(96)80063-4 · Cited by 103
Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects
Tang, C., Godfrey, T., Stawell, R. J., & Nikpour, M. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02886.x · Cited by 101
Vitali, C., Bootsma, H., Bowman, S., Dörner, T., Gottenberg, J., Mariette, X., Ramos‐Casals, M., Ravaud, P., Séror, R., Theander, E., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202565 · Cited by 98
The efficacy of antimalarials in systemic lupus erythematosus.
Nayak, V., & Esdaile, J. M. (1993) · PubMed · Cited by 98
Hage, M. P., Al-Badri, M. R., & Azar, S. T. (2014) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018814547204 · Cited by 98
Spaldin, V., Madden, S. F., Pool, W. F., Woolf, T. F., & Park, B. K. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04316.x · Cited by 96
Current concepts and new ideas on the mechanism of action of quinoline-containing antimalarials
Ginsburg, H., & Geary, T. G. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90038-4 · Cited by 95
Clinical Pharmacokinetics of Slow-Acting Antirheumatic Drugs
Tett, S. E. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199325050-00005 · Cited by 95
Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs
Vezmar, M., & Georges, E. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00270-7 · Cited by 92
Outcome measures for primary Sjögren's syndrome: A comprehensive review
Séror, R., Theander, E., Bootsma, H., Bowman, S., Tzioufas, A. G., Gottenberg, J., Ramos‐Casals, M., Dörner, T., Ravaud, P., Mariette, X., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.010 · Cited by 90
Thiele, D. L., & Lipsky, P. E. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.8.2468 · Cited by 88
Dawson, L. J., Caulfield, V. L., Stanbury, J. B., Field, A. E., Christmas, S. E., & Smith, P. M. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh506 · Cited by 85
Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients
Hereng, T., Lambert, M., HACHULLA, E., Samor, M., Dubucquoi, S., Caron, C., Launay, D., Morell‐Dubois, S., Queyrel, V., & Hatron, P. (2007) · Lupus · doi:10.1177/0961203307084724 · Cited by 84
Antimalarials in rheumatology: Efficacy and safety
Maksymowych, W. P., & RUSSELL, A. S. (1987) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(87)90023-0 · Cited by 82
Titus, E. O. (1989) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198907000-00001 · Cited by 82
Dj, W. (1996) · PubMed · Cited by 82
Martin, A., & Reichlin, M. (1996) · Lupus · doi:10.1177/096120339600500106 · Cited by 82
Hydroxychloroquine: the cornerstone of lupus therapy
Ruiz‐Irastorza, G., & Khamashta, M. A. (2008) · Lupus · doi:10.1177/0961203307086643 · Cited by 81
Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus
Descloux, É., Durieu, I., Cochat, P., Vital-Durand, D., Ninet, J., Fabien, N., & Cimaz, R. (2009) · Rheumatology · doi:10.1093/rheumatology/kep067 · Cited by 80
Prostaglandins: Biology and chemistry of prostaglandins and related eicosanoids
Mikhailidis, D. P., Barradas, M. A., & Jeremy, J. Y. (1989) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(89)90190-7 · Cited by 79
Mackenzie, A. H. (1970) · Arthritis & Rheumatism · doi:10.1002/art.1780130310 · Cited by 79
Carmichael, S., Beal, J. L., Day, R. O., & Tett, S. E. (2002) · PubMed · Cited by 75
Antimalarial drugs for rheumatoid arthritis
Mackenzie, A. H. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90474-6 · Cited by 73
Role of Lysosomes in Hepatic Accumulation of Chloroquine
Macintyre, A. C., & Cutler, D. J. (1988) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600770303 · Cited by 73
The potential place of chloroquine in the treatment of HIV-1-infected patients
Boelaert, J. R., Piette, J. G., & Sperber, K. E. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00140-2 · Cited by 73
Andreas, K., Häupl, T., Lübke, C., Ringe, J., Morawietz, L., Wachtel, A., Sittinger, M., & Kaps, C. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2605 · Cited by 72
Severe hydroxychloroquine myopathy
Abdel-Hamid, H. Z., Oddis, C. V., & Lacomis, D. (2008) · Muscle & Nerve · doi:10.1002/mus.21091 · Cited by 72
Disease-modifying anti-rheumatic drugs
Bachmeier, C., Brooks, P., Day, R. O., Graham, G. G., Littlejohn, G. O., Morand, E. F., Pile, K. D., & Williams, K. M. (2006) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7408-x_28 · Cited by 70
Excretion of chloroquine, dapsone and pyrimethamine in human milk.
Edstein, M., Veenendaal, J. R., Newman, K. T., & Hyslop, R. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb02967.x · Cited by 70
Manku, M. S., & Horrobin, D. F. (1976) · Prostaglandins · doi:10.1016/0090-6980(76)90053-8 · Cited by 69
Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA
Cansu, D. Ü., & Korkmaz, C. (2007) · Rheumatology · doi:10.1093/rheumatology/kem378 · Cited by 68
Fu, S., Björkman, A., Wåhlin, B., et al. (1986) · PubMed · Cited by 67
Will some day PAPS fade into SLE?
Cabral, A., & Alarcón-Segovia, D. (1996) · Lupus · doi:10.1177/096120339600500102 · Cited by 67
Müller-Peddinghaus, R., & Wurl, M. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90423-0 · Cited by 67
Hydroxychloroquine in the treatment of erosive osteoarthritis.
Bryant, L. R., Rosier, K., & Carpenter, M. T. (1995) · PubMed · Cited by 67
Fong, K., & Feng, P.-H. (1996) · Lupus · doi:10.1177/096120339600500104 · Cited by 66
Pharmacogenetics: implications for therapy in rheumatic diseases
Davila, L., & Ranganathan, P. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.117 · Cited by 64
Excretion of hydroxychloroquine in human milk [letter]
Nation, R. L., Hackett, L. P., Dusci, L. J., & Ilett, K. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02358.x · Cited by 64
Knutson, V. P., Ronnett, G. V., & Lane, M. D. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38700-8 · Cited by 62
CYP2C8 and antimalaria drug efficacy
Gil, J., & Berglund, E. G. (2007) · Pharmacogenomics (London) · doi:10.2217/14622416.8.2.187 · Cited by 61
Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats
McChesney, E. W., Banks, W. F., & Sullivan, D. (1965) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(65)90050-5 · Cited by 60
Second-line agents in the treatment of rheumatic diseases
Hunter, J. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.11.1192-b · Cited by 60
Chloroquine Inhibits Tumor Necrosis Factor Production by Human Macrophages In Vitro
Picot, S., Peyron, F., Vuillez, J.-P., Polack, B., & Ambroise-Thomas, P. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.4.830 · Cited by 59
Woźniacka, A. J., Lesiak, A., Boncela, J., Smolarczyk, K., McCauliffe, D. P., & Sysa‐Jędrzejowska, A. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08804.x · Cited by 59
LACK OF A PHARMACOKINETIC INTERACTION BETWEEN AZITHROMYCIN AND CHLOROQUINE
Cook, J., Randinitis, E. J., Bramson, C., et al. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.407 · Cited by 59
French, J. K., Hurst, N. P., O'Donnell, M. L., & Betts, W. H. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.42 · Cited by 58
Achuthan, S., Ahluwalia, J., Shafiq, N., Bhalla, A., Pareek, A., Chandurkar, N., & Malhotra, S. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414546324 · Cited by 58
Collagen degradation in an experimental inflammatory lesion: studies on the role of the macrophage.
Etherington, D. J., Pugh, D., & Silver, I. A. (1981) · PubMed · Cited by 58
Heart rate variability and cardiac autonomic function in systemic lupus erythematosus
Laganà, B., Tubani, L., Maffeo, N., Vella, C., Makk, E., Baratta, L., & Bonomo, L. (1996) · Lupus · doi:10.1177/096120339600500110 · Cited by 56
Pussard, E., Verdier, F., & Blayo, M. C. (1986) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)83258-2 · Cited by 55
Antioxidant action of antimalarials.
Miyachi, Y., Yoshioka, A., Imamura, S., & Niwa, Y. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.3.244 · Cited by 55
van den Borne, B. E., Landewé, R., Thè, H. S. G., Rietveld, J. H., Zwinderman, A. H., Bruyn, G. A., Breedveld, F. C., & Dijkmans, B. A. C. (1998) · PubMed · Cited by 54
Hydroxychloroquine in human breast milk
�stensen, M., Brown, N. D., Chiang, P. K., & Aarbakke, J. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00543338 · Cited by 53
Hostetler, K. Y., & Richman, D. D. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90295-7 · Cited by 52
Lupus in Baltimore: evidence-based ‘clinical pearls’ from the Hopkins Lupus Cohort
Petri, M. (2005) · Lupus · doi:10.1191/0961203305lu2230xx · Cited by 52
Chafin, C. B., Regna, N. L., Hammond, S. E., & Reilly, C. M. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.09.013 · Cited by 49
Lai, J., Ho, L., Lu, K., Chang, D., Shaio, M., & Han, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6914 · Cited by 48
MIF: Mood Improving/Inhibiting Factor?
Bloom, J., & Al‐Abed, Y. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-11 · Cited by 48
Placental and Milk Transfer of Chloroquine in Humans
Akintonwa, A., Gbajumo, S. A., & Mabadeje, A. F. B. (1988) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198802000-00004 · Cited by 48
Antimalarial Drugs in Systemic Lupus Erythematosus: Use in Pregnancy
Borden, M. B., & Parke, A. L. (2001) · Drug Safety · doi:10.2165/00002018-200124140-00004 · Cited by 47
Self-citationde Oliveira, A. R. M., Cardoso, C. D., & Bonato, P. S. (2007) · Electrophoresis · doi:10.1002/elps.200600420 · Cited by 46
Vuolteenaho, K., Kujala, P. M., Moilanen, T. P. S., & Moilanen, E. (2005) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740510026797 · Cited by 46
Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study
Saviola, G., Abdì-Alì, L., Campostrini, L., Sacco, S., Baiardi, P., Manfredi, M., Mannoni, A., & Benucci, M. (2011) · Modern Rheumatology · doi:10.1007/s10165-011-0506-8 · Cited by 45
Ducharme, J., Fieger, H., Ducharme, M. P., Khalil, S., & Wainer, I. W. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05768.x · Cited by 44
Rheumatoid arthritis medications and lactation
Sammaritano, L. R., & Bermas, B. L. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000055 · Cited by 44
Çankaya, H., Alpöz, E., Karabulut, G., Güneri, P., Boyacıoğlu, H., & Kabasakal, Y. (2010) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2010.02.032 · Cited by 42
Cowey, F. K., & Whitehouse, M. W. (1966) · Biochemical Pharmacology · doi:10.1016/0006-2952(66)90272-3 · Cited by 42
Antimalarial Drugs: Mechanisms of Action in Autoimmune Disease and Prospects for Drug Development
Fox, R. I. (1995) · BioDrugs · doi:10.1007/bf03259287 · Cited by 41
Ashraf, T., Jiang, W., Hoque, M. T., Henderson, J., Wu, C., & Bendayan, R. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-91 · Cited by 40
Kao, K.-J. (1988) · Transfusion · doi:10.1046/j.1537-2995.1988.28188127942.x · Cited by 40
Heart rate variability in patients with systemic lupus erythematosus
Stein, K., McFarlane, I., Goldberg, N., & Ginzler, E. M. (1996) · Lupus · doi:10.1177/096120339600500109 · Cited by 38
Malbica, J. O., & Hart, L. G. (1971) · Biochemical Pharmacology · doi:10.1016/0006-2952(71)90401-1 · Cited by 38
Excretion of chloroquine and desethylchloroquine in human milk.
Ogunbona, F. A., Onyeji, C. O., Bolaji, O. O., & Torimiro, S. E. A. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03078.x · Cited by 38
Sanders, M. E. (2000) · PubMed · Cited by 37
Mullié, C., Jonet, A., Desgrouas, C., Taudon, N., & Sonnet, P. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-65 · Cited by 37
Padol, I. T., & Hunt, R. H. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/kep225 · Cited by 37
The Impact of Stereoisomerism in Bioequivalence Studies
Midha, K. K., McKay, G., Rawson, M. J., & Hubbard, J. W. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9703683 · Cited by 36
Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity
Costa, L. M., Ibáñez, M. V., Murcia-Bello, C., Epifanio, I., Verdejo-Gimeno, C., Beltrán, E., & Marco-Ventura, P. (2013) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2013.03.018 · Cited by 35
The inhibition of gluconeogenesis by chloroquine contributes to its hypoglycaemic action
Jarzyna, R., Kiersztan, A., Lisowa, O., & Bryła, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01221-3 · Cited by 34
Alisky, J. M., Chertkova, E. L., & Iczkowski, K. A. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.059 · Cited by 34
Pharmacokinetics and Cellular Uptake of 4-Aminoquinoline Antimalarials
Cutler, D. J., Macintyre, A. C., & Tett, S. E. (1988) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9160-8_13 · Cited by 34
Clegg, D. O., Dietz, F., Duffy, J., et al. (1997) · PubMed · Cited by 32
Tett, S. E., McLachlan, A. J., Cutler, D. J., & Day, R. O. (1994) · Chirality · doi:10.1002/chir.530060420 · Cited by 31
McChesney, E. W., & Fitch, C. D. (1984) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69254-3_1 · Cited by 31
Effect of Gold Salts and Antimalarials on the Rheumatoid Factor in Rheumatoid Arthritis
Klinefelter, H. F., & Achurra, A. (1973) · Scandinavian Journal of Rheumatology · doi:10.3109/03009747309097086 · Cited by 30
Towards evidence-based treatment of thrombotic antiphospholipid syndrome
Derksen, R. H. W. M., & de Groot, P. G. (2010) · Lupus · doi:10.1177/0961203309361483 · Cited by 30
O’Dell, J. R., Petersen, K., Leff, R. D., PALMER, W. R., Schned, E. S., Blakely, K., Haire, C. E., & Fernandez, A. (2006) · PubMed · Cited by 29
Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study
Saviola, G., Abdì-Alì, L., Campostrini, L., et al. (2012) · Modern Rheumatology · doi:10.3109/s10165-011-0506-8 · Cited by 29
Kingsbury, S. R., Tharmanathan, P., Adamson, J., Arden, N., Birrell, F. N., Cockayne, S., Dickson, J., Doherty, M., Dziedzic, K., Grainger, A. J., et al. (2013) · Trials · doi:10.1186/1745-6215-14-64 · Cited by 28
Namazi, M. R. (2009) · Lupus · doi:10.1177/0961203308097574 · Cited by 26
Das, S. K., Pareek, A. K., Mathur, D. S., Wanchu, A., Srivastava, R. N., Agarwal, G. G., & Chauhan, R. S. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x219634 · Cited by 26
Effect of Hydroxychloroquine on the Lipid Profile of Patients with Sjögren Syndrome
Migkos, M. P., Markatseli, T. E., Iliou, C., Voulgari, P. V., & Drosos, A. A. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.131156 · Cited by 26
Carmichael, S., Day, R. O., & Tett, S. E. (2013) · Internal Medicine Journal · doi:10.1111/imj.12100 · Cited by 25
Jokar, M. H., Mirfeizi, Z., & Keyvanpajouh, K. (2013) · PubMed · Cited by 24
Detert, J., Klaus, P., Listing, J., Höhne-Zimmer, V., Braun, T., Wassenberg, S., Rau, R., Buttgereit, F., & Burmester, G. R. (2014) · Trials · doi:10.1186/1745-6215-15-412 · Cited by 24
O’Dell, J. R. (1998) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70020-x · Cited by 24
Dixon, J. S., Pickup, M. E., Bird, H. A., Lee, M. R., Wright, V. A., & Downie, W. (1981) · Annals of the Rheumatic Diseases · doi:10.1136/ard.40.5.480 · Cited by 23
Churchill, F. C., Mount, D. L., & Schwartz, I. K. (1983) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)84414-x · Cited by 23
Vuolteenaho, K., Moilanen, T. P. S., Hämäläinen, M., & Moilanen, E. (2003) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740310000355 · Cited by 23
Determination of Chloroquine and Monodesethylchloroquine in Hair
Viala, A., Deturmeny, E., Aubert, C., Estadieu, M., Durand, A., Cano, J. P., & Delmont, J. P. (1983) · Journal of Forensic Sciences · doi:10.1520/jfs11600j · Cited by 22
Glaumann, H., Ahlberg, J., Berkenstam, A. L., & Henell, F. (1986) · Experimental Cell Research · doi:10.1016/0014-4827(86)90567-7 · Cited by 22
BRANDRISS, M. W., & Schlesinger, J. J. (1984) · Journal of General Virology · doi:10.1099/0022-1317-65-4-791 · Cited by 20
Hunneyball, I. M., CROSSLEY, M. J., & Spowage, M. (1986) · Inflammation Research · doi:10.1007/bf01965003 · Cited by 20
Insights from pharmacokinetic and pharmacodynamic studies of hydroxychloroquine.
Tett, S. E., McLachlan, A. J., Day, R. O., & Cutler, D. (1993) · PubMed · Cited by 20
Hedin, U., & Thyberg, J. (1985) · PubMed · Cited by 20
Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report.
Wei, L.-C., Chen, S. N., Ho, C. L., Kuo, Y., & Ho, J. D. (2001) · PubMed · Cited by 19
Effect of antimalarial drugs on stimulation and interleukin 2 production of human lymphocytes
Bygbjerg, I. C., Svenson, M., Theander, T. G., et al. (1987) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(87)90027-0 · Cited by 19
Hurst, N. P., French, J. K., Gorjatschko, L., & Betts, W. H. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.10.750 · Cited by 19
Neil, H. A. W., Perera, R., Armitage, J., Farmer, A. A., Mant, D., & Durrington, P. N. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01828.x · Cited by 17
Chloroquine- and primaquine-induced alterations of glucose metabolism in the uninfected red cell
Kelman, S. N., Sullivan, S. G., & Stern, A. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90287-2 · Cited by 16
Lack of Pharmacokinetic Interaction Between Chloroquine and Imipramine
Onyeji, C. O., Toriola, T. A., & Ogunbona, F. A. (1993) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199302000-00008 · Cited by 15
Cited by
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., & Xu, J. (2018) · Bone Research · doi:10.1038/s41413-018-0016-9 · Cited by 1,767
Mechanisms of action of hydroxychloroquine and chloroquine:implications for rheumatology
Schrezenmeier, E., & Dörner, T. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0372-x · Cited by 1,468
Tang, W., Cao, Z., Han, M., Wang, Z., Chen, J., Sun, W., Wu, Y., Xiao, W., Liu, S., Chen, E., et al. (2020) · BMJ · doi:10.1136/bmj.m1849 · Cited by 1,135
Bhimraj, A., Morgan, R. L., Shumaker, A. H., Lavergne, V., Baden, L., Cheng, V. C.-C., Edwards, K. M., Gandhi, R., Muller, W. J., O’Horo, J. C., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa478 · Cited by 1,033
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
Chen, Z., Hu, J., Zhang, Z., Jiang, S., Han, S., Yan, D., Zhuang, R., Hu, B., & Zhang, Z. (2020) · medRxiv · doi:10.1101/2020.03.22.20040758 · Cited by 847
Metadata
- Authors
- Rainsford, K. D., Parke, A. L., Clifford-Rashotte, M., & Kean, W. F.
- Venue
- Inflammopharmacology
- Published
- 2015-08-06
- Volume
- 23
- Issue
- 5
- Pages
- 231-269
- ISSN
- 0925-4692 (ISSN-L)
- 1568-5608
- OpenAlex
- W1959216194
- Cited by
- 543
- References
- 217
- FWCI
- 23.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.